Related Experiment Videos
A recombinant E1-deleted porcine adenovirus-3 as an expression vector
Alexander Zakhartchouk1, Yan Zhou, Suresh Kumar Tikoo
1Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.
Virology
|September 5, 2003
Summary
Replication-defective porcine adenovirus (PAV) vectors are promising for vaccines. Researchers created a cell line supporting E1-deleted PAVs, enabling the development of a novel vaccine vector expressing GFP in human cells.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Replication-defective porcine adenoviruses (PAVs) are valuable as vaccine vectors.
- Developing E1-deleted PAV vectors requires specific cell lines for propagation.
Purpose of the Study:
- To generate a cell line that supports the replication of E1-deleted PAV-3.
- To create and characterize novel recombinant PAV vectors for potential vaccine applications.
Main Methods:
- Transfection of VIDO R1 cells with PAV-3 E1B(large) sequences to create the VR1BL cell line.
- Rescue and propagation of E1-deleted PAV vectors (PAV507, PAV227) using the VR1BL cell line.
- Construction and characterization of a recombinant PAV vector (PAV219) expressing GFP.
Main Results:
- The VR1BL cell line successfully expressed PAV-3 E1B(large) and complemented E1-deleted PAVs.
- Recombinant PAV227 with complete E1 deletion was rescued and replicated in VR1BL cells, with E1B(large) essential for PAV-3 replication.
- Recombinant PAV219 successfully transduced human cell lines and expressed GFP.
Conclusions:
- The VR1BL cell line is effective for generating E1-deleted PAV vectors.
- PAV-3 E1B(large) is crucial for viral replication.
- Recombinant PAV vectors, like PAV219, show potential for gene delivery and vaccination applications.